Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tectonic Therapeutic (TECX) Accounts Payables (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Accounts Payables data on record, last reported at $2.6 million in Q1 2026.

  • On a quarterly basis, Accounts Payables fell 59.16% to $2.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.6 million, a 59.16% decrease, with the full-year FY2025 number at $1.1 million, up 11.99% from a year prior.
  • Accounts Payables reached $2.6 million in Q1 2026 per TECX's latest filing, up from $1.1 million in the prior quarter.
  • Over the last five years, Accounts Payables for TECX hit a ceiling of $6.3 million in Q1 2025 and a floor of $28000.0 in Q2 2022.
  • A 5-year average of $1.8 million and a median of $1.1 million in 2025 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: tumbled 98.62% in 2022, then surged 3725.0% in 2023.
  • Tracing TECX's Accounts Payables over 5 years: stood at $384000.0 in 2022, then grew by 6.51% to $409000.0 in 2023, then surged by 138.63% to $976000.0 in 2024, then rose by 11.99% to $1.1 million in 2025, then surged by 133.67% to $2.6 million in 2026.
  • Business Quant data shows Accounts Payables for TECX at $2.6 million in Q1 2026, $1.1 million in Q4 2025, and $1.5 million in Q3 2025.